Serencroft Investments
Backing innovation that improves health outcomes, supports earlier intervention, and strengthens coordinated care delivery.
Introduction
Serencroft is committed to responsible growth and long-term impact in healthcare. Alongside our care services, we invest in HealthTech and MedTech businesses that improve outcomes, enable earlier intervention, and support more joined-up models of care delivery.
We focus on supporting high-growth start-up and scale-up companies in technology, MedTech, and health, with particular emphasis on:
Improving patient outcomes through smarter tools and earlier detection
Enabling more efficient, coordinated delivery of care
Supporting preventative, data-driven approaches to health
Aligning with ethical, sustainable, long-term value creation
Our Investments and Partnerships
Tympa Health
Tympa Health enables earlier identification and treatment pathways in ear and hearing healthcare through innovative diagnostic and treatment solutions.
Semble
Semble is a digital healthcare platform designed to streamline care coordination, patient management, and clinical workflows.
Thena Capital
Thena Capital invests in next-generation health and medical innovation, engaging with technologies that are shaping the future of care.
Hayes Renal Unit
In partnership with the NHS to support clinical infrastructure, including dialysis capacity and specialist public-private healthcare collaborations.